Picture of BioPorto A/S logo

BIOPOR BioPorto A/S Cashflow Statement

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for BioPorto A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-65.3-81.5-61.2-75.5-86.1
Depreciation
Non-Cash Items-0.6569.191.43-3.261.58
Unusual Items
Other Non-Cash Items
Changes in Working Capital-315.91.61-7.254.94
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-64.6-52.5-55.5-83.6-77.1
Capital Expenditures-0.389-0.471-0.039-0.350
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.023-0.032-0.2381.541.27
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.412-0.503-0.2771.191.27
Financing Cash Flow Items-0.011-7.67-1.63-3.39-1.12
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.188.740.875.571.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-62.436.3-15.4-6.74-4.77